Publication bias was evaluated using a funnel plot test, and sensitivity analysis was used to assess the robustness of the studies
Brand-name tirzepatide by Eli Lilly Mounjaro is an FDA-approved brand-name tirzepatide originally indicated for type 2 diabetes, with dual GLP-1 and GIP receptor action that has shown significant weight loss results in clinical trials
Semasize-2mg (8mg/3ml) Disposable Pen Solution for Injection 1's is not recommended for use in children, during pregnancy, or while breastfeeding
Ingredients Inulin (oligosaccharide) (from chicory root)
A., Fauth, C., Bergheim, C., Meierhofer, D., Radmayr, D., Zschocke, J., Koch, J., and Sperl, W